Session Abstract – PMWC 2020 Silicon Valley


The latest treatment options are not an option if you can’t get or afford them. Learn about the novel strategies top docs use to access breakthrough tests and therapies for their patients through clinical trials, expanded access and contingent reimbursement.

 Session Chair Profile

Managing Director, Three-Sixty Advisory Group; Venture Partner, Wavemaker 360 Health

Biography
Eric N. Marton has 25+ years of experience in healthcare and currently serves as Managing Director at Three-Sixty Advisory Group and Venture Partner at Wavemaker 360 Health. Prior to this, Eric was recruited by private equity firm BlueMountain Capital to serve as Chief Strategy Officer of Verity Health – with six hospital campuses and numerous ambulatory centers. Concurrently, Eric was CEO of the Verity Physician Network and CEO of Verity subsidiary, Surgical Partners of California. Eric’s other past positions include Executive Director at Cedars-Sinai Health System, CEO of the California Heart Center at UCLA, and Managing Partner at Catalyst Venture Group.


 Speaker Profile

M.D., Chief Clinical Officer, CTCA Health

Biography
For over 30 years Dr. Markman has been engaged in clinical research in the area of gynecologic malignancies. Dr. Markman has been the primary author or co-author on over 1,000 published peer-reviewed manuscripts, reviews, book chapters, editorials or abstracts, and has written, edited or co-edited 23 books on various topics in the management of malignant disease. In 2011, Dr. Markman received the American Society of Clinical Oncology (ASCO) Statesman Award, which recognizes individual members who have shown extraordinary volunteer service, dedication and commitment to ASCO, their hospital community and the patients they serve for at least 20 years. In May, 2018, Dr. Markman was named by OncLive® to an elite group of the 2018 Giants of Cancer Care® recognition program which celebrates pioneers, innovators and leaders who have made remarkable achievements in oncology research and clinical practice. Dr. Markman was selected in recognition of his contributions in gynecologic cancers.


 Speaker Profile

M.D., Chief Physician Executive of Operations, Sutter Health

Biography
Dr. Vial is a practicing cardiac surgeon who also serves as the Chief Physician Executive of Operations for Sutter Health and sits on the system’s Operations Leadership Team (OLT), chaired by Sutter Health’s Chief Operating Officer. In his leadership role, Dr Vial acts as a principal author of clinical strategy deployment, responsible for unifying clinical program building, business development, and operational efficiency across the continuum of care. An important focus of his work is the extension of ongoing specialty service line integration efforts, informing not only operations but also analytics and innovation through interdisciplinary clinical leadership platforms. From the clinical practice perspective, Dr. Vial is particularly interested in structural heart disease, focusing on minimally invasive cardiothoracic surgery and catheter-based valve repair/replacement. He received his bachelor’s degree and medical doctorate from Stanford University. In addition, Dr. Vial earned a master’s of philosophy at Cambridge University in England, while also completing a postdoctoral fellowship in transplant immunology. He received his general surgical and cardiothoracic surgical training at Stanford University Medical Center.


 Speaker Profile

Founder & CEO, OctX

Biography
Martin Naley recently founded a company called OctX. It's is an oncology trial information exchange, providing accurate, complete, and up-to-date information about clinical trials, designed to help everyone who is helping patients find cancer trial options. Before founding OctX, Martin was Program Lead, Clinical Trials Acceleration at Biden Cancer Initiative, where he developed the Oncology Clinical Trial Information Commons, an alliance to overcome systemic barriers affecting clinical trial enrollment. Martin continues to lead that alliance as a consultant at Cancer Commons. Martin has created and led technology-based businesses in the fields of digital health, clinical trial matching, real-world data, and precision medicine. Through his entrepreneurial experience, he has developed deep knowledge about health data access, technology platforms, and the interests of patients, providers, and drug developers. Martin began his career with 15 years in management and executive positions at Life Technologies, a leading provider of scientific tools powering personalized medicine.


 Speaker Profile

VP of Innovation, Anthem, Inc.

Biography
Mariya Filipova leads Anthem’s Innovation function and oversees a network of ecosystem hubs across the country. She also leads a portfolio of initiatives that accelerate Anthem’s transformation into an AI-first company taking full advantage of exponential technologies and new business models. Mariya’s past experience as an entrepreneur and wall street analyst has shaped her perspective on transformation in closely regulated industries in Europe and the United States. She is a trusted advisor to both healthcare veterans and new entrants, from established industry leaders to start-ups in e-commerce, retail, and tech. Mariya previously led Deloitte’s global Future of Work Program Office, a portfolio of investments that use exponential technologies (e.g. blockchain, artificial intelligence) to redefine the way we do and monetize work. She holds an MBA from Harvard Business School and a BA in Economics, summa cum laude, from Mount Holyoke College. She remains active in her alumni community where she serves on the Board of Governors for the Harvard Business School Association of Boston. She is currently based in Boston, MA.